Heart Failure-Related Death in Subjects With Atrial Fibrillation in the United States, 1999 to 2020

Marco Zuin1, Matteo Bertini1, Francesco Vitali1

  • 1Cardiology Unit, Department of Translational Medicine Sant'Anna University Hospital, University of Ferrara Ferrara Italy.

Insights

Heart failure deaths are rising in US adults with atrial fibrillation. This trend is particularly concerning in men, White individuals, and younger populations, with a notable increase observed after 2011.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Population-based data on heart failure (HF)-related mortality in patients with atrial fibrillation (AF) are limited.
  • Understanding these trends is crucial for public health initiatives and clinical practice.
  • Previous studies have not comprehensively assessed long-term mortality trends in this specific patient group.

Purpose of the Study:

  • To assess trends in HF-related death among US adults with AF over a 21-year period (1999-2020).
  • To examine demographic and regional differences in HF-related mortality within the AF population.
  • To identify specific subgroups experiencing disproportionate increases in mortality.

Main Methods:

  • Utilized the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database.
  • Analyzed age-adjusted mortality rates per 100,000 individuals with AF aged 15 years and older.
  • Employed joinpoint regression to calculate the average annual percent change (AAPC) and identify significant trend shifts.

Main Results:

  • Over 916,000 HF-related deaths occurred in US adults with AF between 1999 and 2020.
  • Overall age-adjusted mortality rates increased by 4.1% annually, with a steeper rise of 6.8% after 2011.
  • Significant increases were observed in men (+4.8% AAPC), White individuals (+4.2% AAPC), and those under 65 years (+7.5% AAPC).
  • The South region accounted for the highest percentage of deaths (32.8%).
  • An excess of HF-related deaths was noted in patients over 65 during the first year of the COVID-19 pandemic.

Conclusions:

  • A concerning upward trend in HF-related mortality among patients with AF has been identified in the US over the past two decades.
  • Targeted interventions are needed to address rising mortality rates in specific demographic groups.
  • Further research should investigate the factors contributing to this increase, especially in light of recent public health events.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
945
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
662